We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+14.61%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$51.6B
AUM Growth
+$5.68B
Cap. Flow
-$429M
Cap. Flow %
-0.83%
Top 10 Hldgs %
17.19%
Holding
3,020
New
40
Increased
1,306
Reduced
1,586
Closed
73

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$73.8M
2
AMZN icon
Amazon
AMZN
+$68.6M
3
AAPL icon
Apple
AAPL
+$64.9M
4
MSFT icon
Microsoft
MSFT
+$61.4M
5
META icon
Meta Platforms (Facebook)
META
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 18.09%
2 Financials 15.13%
3 Healthcare 13.65%
4 Consumer Discretionary 10.39%
5 Industrials 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTSH
2226
DELISTED
Tile Shop Holdings
TTSH
$636K ﹤0.01%
112,421
+1,172
+1% +$7.62K
KREF
2227
KKR Real Estate Finance Trust
KREF
$480M
$632K ﹤0.01%
31,547
+1,827
+6% +$36.9K
STML
2228
DELISTED
Stemline Therapeutics, Inc.
STML
$632K ﹤0.01%
49,184
+12,046
+32% +$136K
ESTC icon
2229
Elastic
ESTC
$7.18B
$631K ﹤0.01%
7,898
+1,327
+20% +$111K
FTR
2230
DELISTED
Frontier Communications Corp.
FTR
$631K ﹤0.01%
317,255
-350
-0.1% -$850
CPRX
2231
DELISTED
Catalyst Pharmaceutical
CPRX
$629K ﹤0.01%
123,245
-3,454
-3% -$10.2K
LASR icon
2232
nLIGHT
LASR
$4.34B
$628K ﹤0.01%
28,200
-233
-0.8% -$4.72K
TGTX icon
2233
TG Therapeutics
TGTX
$7.66B
$625K ﹤0.01%
77,713
-1,185
-2% -$6.4K
OEF icon
2234
iShares S&P 100 ETF
OEF
$20.4B
$624K ﹤0.01%
4,977
+1,973
+66% +$238K
PETQ
2235
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$623K ﹤0.01%
19,840
-399
-2% -$11.3K
CTMX icon
2236
CytomX Therapeutics
CTMX
$734M
$621K ﹤0.01%
57,787
-1,356
-2% -$20K
WINA icon
2237
Winmark
WINA
$1.28B
$615K ﹤0.01%
3,260
-63
-2% -$10.4K
RST
2238
DELISTED
ROSETTA STONE INC
RST
$615K ﹤0.01%
28,145
+302
+1% +$5.27K
NVEC icon
2239
NVE Corp
NVEC
$619M
$613K ﹤0.01%
6,264
-47
-0.7% -$4.54K
TFSL icon
2240
TFS Financial
TFSL
$5.04B
$613K ﹤0.01%
37,208
-7,120
-16% -$119K
DERM
2241
DELISTED
Dermira, Inc.
DERM
$613K ﹤0.01%
45,272
-1,081
-2% -$9.01K
EAF icon
2242
GrafTech
EAF
$201M
$611K ﹤0.01%
4,777
-527
-10% -$70K
LQDT icon
2243
Liquidity Services
LQDT
$1.3B
$610K ﹤0.01%
79,058
+135
+0.2% +$1.01K
TOWR
2244
DELISTED
Tower International, Inc.
TOWR
$608K ﹤0.01%
28,910
+778
+3% +$20K
DVAX
2245
DELISTED
Dynavax Technologies
DVAX
$607K ﹤0.01%
83,089
-1,326
-2% -$13K
CNXN icon
2246
PC Connection
CNXN
$2.2B
$605K ﹤0.01%
16,509
-195
-1% -$7.01K
CLNE icon
2247
Clean Energy Fuels
CLNE
$405M
$604K ﹤0.01%
195,595
-2,245
-1% -$4.99K
KURA icon
2248
Kura Oncology
KURA
$822M
$602K ﹤0.01%
36,309
-809
-2% -$12.5K
PES
2249
DELISTED
Pioneer Energy Services Corp.
PES
$596K ﹤0.01%
336,828
+76,755
+30% +$132K
KEYW
2250
DELISTED
The KEYW Holding Corporation
KEYW
$595K ﹤0.01%
69,048
-1,052
-2% -$7.65K

Similar funds

RhumbLine Advisers's Q1 2019 Portfolio in Review

As of Q1 2019, RhumbLine Advisers held 3,020 positions worth $51.6B, up 12% from $46B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 3.7%. RhumbLine Advisers opened 40 new positions and exited 73, leaving the 3,020-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2019 buy was Fox Class A: 602,636 shares worth $22.1M.
  • RhumbLine Advisers added most to Walt Disney in Q1 2019, an estimated $73.8M increase.
  • RhumbLine Advisers's biggest Q1 2019 reduction was Wells Fargo, cutting an estimated $16.4M.
  • RhumbLine Advisers fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $89.7M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $51.6B portfolio in Q1 2019.
  • RhumbLine Advisers opened 40 new positions and closed 73 in Q1 2019.
  • RhumbLine Advisers's portfolio value rose 12% quarter-over-quarter to $51.6B.

Based on RhumbLine Advisers's 13F filing for Q1 2019, filed 1 May 2019.